Mechanism underlying the reversal of contractility dysfunction in experimental colitis by cyclooxygenase-2 inhibition

Inflammopharmacology

Volumn 14, Issue 1-2, 2006, Pages 28-35

  Khan, I ^a   Oriowo, M A ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Colitis; ERK; IL 1 ; Inflammation; Muscle contraction; p38

Indexed keywords

CARBACHOL; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MALONALDEHYDE; MELOXICAM; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOPEROXIDASE; PHOSPHATE BUFFERED SALINE; PROSTAGLANDIN E2; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE;

ANIMALS; BLOTTING, WESTERN; CARBACHOL; COLITIS; COLON; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GASTROINTESTINAL MOTILITY; ISOMETRIC CONTRACTION; MALE; MALONDIALDEHYDE; MUSCLE, SMOOTH; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THIAZINES; THIAZOLES; TRINITROBENZENESULFONIC ACID;

EID: 33646244499     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-006-1507-7     Document Type: Article

References (51)

1. Amano, S., Naganuma, K., Kawata, Y. et al. (1996). Prostaglandin E2 stimulates osteoclast formation via endogenous IL-1 beta expressed through protein kinase A. J. Immunol. 156, 1931-1936.
2. Bhat, N. R., Zhang, P., Lee, J. C. et al. (1998). Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633-1641.
3. Blennerhassett, M. G., Bovell, F. M., Lourenssen, S. et al. (1999). Characteristics of inflammation-induced hypertrophy of rat intestinal smooth muscle cell. Dig. Dis. Sci. 44, 1265-1272.
4. Bradley, P. P., Priebat, D. A., Christensen, R. D. et al. (1982). Measurement of cutaneous inflammation, estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78, 206-209.
5. Cao, W., Sohn, U. D., Bitar, K. N., et al. (2003). MAPK mediates PKC-dependent contraction of cat esophageal and lower esophageal sphincter circular smooth muscle. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G86-95.
6. Cheng, H. F., Harris, R. C. (2005). Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors. Curr. Pharm. Des. 11, 1795-1804.
7. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. et al. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
8. Cipolla, G., Crema, F., Sacco, S. et al. (2002). Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease, current perspectives. Pharmacol. Res. 46, 1-6.
9. Davis, R. J. (1994). MAPKs, new JNK expand the group. Trends Biochem Sci 19, 470-473.
10. Dudhgaonkar, S. P., Tandan, S. K., Bhat, A. S. et al. (2005). Synergistic anti-inflammatory interaction between meloxicam and aminoguanidine hydrochloride in carrageenan-induced acute inflammation in rats. Life Sci. 2005 Aug 15 [Epub ahead of print.
11. Famaey, J. P., Fontaine, J. and Reuse, J. (1977). The effects of various non-steroidal anti-inflammatory drugs on the cholinergic and histamine-induced contractions of guinea-pig ileum. Br. J. Pharmacol. 60, 165-171.
12. Giuliano, F., Ferraz, J. G., Pereira, R. et al., 2001. Cyclooxygenase selectivity of non-steroid anti-inflammatory drugs in humans: ex vivo evaluation. Eur. J. Pharmacol. 426, 95-103.
13. Grossi, L., McHugh, K., Collins, S. M. (1993). On the specificity of altered muscle function in experimental colitis in rats. Gastroenterology 104, 1049-1056.
14. Iseri, S.O., Sener, G., Saglam, B. et al. (2005). Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides, 26, 483-491.
15. Kankuri, E., Vaali, K., Korpela, R. et al. (2001). Effects of a Cox-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. Inflammation 25, 301-310.
16. Karateev, A. E. (2005). Gastroduodenal safety of selective inhibitors of cyclooxigenase-2: practical validation. Ter Arkh. 77, 69-72.
17. Karmeli, F., Cohen, P., Rachmilewitz, D. (2000). Cyclo-oxygenase-2 inhibitors ameliorate the severity of experimental colitis in rats. Eur. J. Gastroenterol. Hepatol. 12, 223-231.
18. Khan, I., Al-Awadi, F. M. (1997). Colonic muscle enhances the production of interleukin-1β messenger RNA in experimental colitis. Gut 40, 307-312.
19. + exchanger isoform NHE-1. J. Pharmacol. Exp. Ther. 285, 869-875.
20. Khan, I. (1999). Molecular basis of altered contractility in experimental colitis, expression of L-type calcium channel. Dig. Dis. Sci. 44, 1525-1530.
21. + exchanger isoform-1 in human inflammatory bowel disease. Can. J. Gastroenterol. 17, 31-36.
22. Khan, I., Al-Awadi, F. M., Thomas, N. (2001). In vivo inhibition of cyclooxygenase-2 by a selective phosphorothioated oligonucleotide. Antisense Nucleic Acids Drug Dev. 11(4), 199-207.
23. + exchanger isoform-3 by prolonged stimulation of rats with adrenocorticotropic hormone. Endocrine 16, 189-194.
24. Khan, I., Thomas, N., Haridas, S. (2001). Expression and sub cellular localization of the sodium hydrogen exchanger isoform-1 in rat tissues, A possible functional relevance. Molecular Cellular Biochemistry 219, 153-161.
25. Khan, I., Al-Awadi, F. M., Thomas, N. et al. (2002). Cyclooxygenase-2 inhibition and experimental colitis, beneficial effects of phosphorothioated antisense oligonucleotide and meloxicam. Scand. J. Gastroenterol. 37, 1428-1436.
26. Khan, I., Oriowo, M. A., Anim, J. T. (2005). Amelioration of experimental colitis by Na-H exchanger-1 inhibitor amiloride is associated with reversal of IL-1β and ERK MAP kinase. Scand. J. Gastroenterol. 40, 578-585.
27. 2+ channels and its reversal by NF-kappaB inhibitors in Crohn's colitis model. Am. J. Physiol. 285, G483-493.
28. Kulkarni, S. K., Jain, N. K., Singh, A. (2000). Cyclooxygenase isoenzymes and newer therapeutic potential for selective Cox-2 inhibitors. Methods Find. Exp. Clin. Pharmacol. 22, 291-298.
29. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227, 680-685.
30. Linden, D. R., Sharkey, K. A., Ho, W. et al. (2004). Cyclooxygenase-2 contributes to dysmotility and enhanced excitability of myenteric AH neurones in the inflamed guinea pig distal colon. J. Physiol. 557, 191-205.
31. Lodato, R. F., Khan, A. R., Zembowicz, M. J. (1999). Roles of IL-1 and TNF in the decreased ileal muscle contractility induced by lipopolysaccharide. Am. J. Physiol. 276, G1356-1362.
32. Martin, A. R., Villegas, I., LaCasa, C. et al. (2003). The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats. Eur. J. Pharmacol. 481, 281-291.
33. Miedzybrodzki, R. (2004). Trends in nonsteroidal anti-inflammatory drug development and application). Postepy. Hig. Med. Dosw. (Online) 58, 438-448.
34. Morris, G. P., Beck, P. L., Herridge, M. S. et al. (1989). Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795-803.
35. Ohkawa, H., Ohishi, N. and Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
36. Pizarro, T. T., Arseneau, K. O., Bamias, G. et al. (2000). Mouse models for the study of Crohn's disease. Trends Mol. Med. 9, 218-222.
37. Pype, J. L., Xu, H., Schuermans, M. et al. (2001). Mechanisms of interleukin 1beta-induced human airway smooth muscle hyporesponsiveness to histamine. Involvement of p38 MAPK NF-kappaB. Am. J. Respir. Crit. Care Med. 163, 1010-1017.
38. Reuter, B. K., Asfaha, S., Buret, A. et al. (1996). Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest. 98, 2076-2085.
39. Salinthone, S., Singer, C. A., Gerthoffer, W. T. (2004). Inflammatory gene expression by human colonic smooth muscle cells. Am. J. Physiol. 287, G627-637.
40. Sethi, A. K., Sarna, S. K. (1991). Colonic motor response to a meal in acute colitis. Gastroenterology 101, 1537-1546.
41. Simon, L.S. (2000). Role and regulation of cyclooxygenase-2 during inflammation. Am. J. Med. 106, 37S-42S.
42. Singh, V. P., Patil, C. S., Jain, N. K. et al. (2003). Singh A, Kulkarni SK. Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats. Prostaglandins Other Lipid Mediat. 71, 163-175.
43. Singh, V. P., Patil, C. S., Jain, N. K. et al. (2004). Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats. Pharmacology 72, 77-84.
44. Snape, W. J. Jr, Matarazzo, S. A., Cohen, S. (1981). Abnormal gastrocolonic response in patients with ulcerative colitis. Gut 21, 392-396.
45. tenHove. T., van den Blink, B., Pronk, I. et al. (2002). Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis. Gut 50, 507-512.
46. Thulesius, O., Angelo-Khattar, M. (1985). The effect of indomethacin on the motility of isolated sheep ureters. Acta Pharmacol. Toxicol. (Copenh) 56, 298-301.
47. VanHecken, A., Schwartz, J. I., Depre, M. et al. (2000). Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on cox-2 versus cox-1 in healthy volunteers. J. Clin. Pharmacol. 40, 1109-1120.
48. Waetzig, G. H., Seegert, D., Rosenstiel, P. et al. (2002). p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J. Immunol. 168, 5342-5351.
49. Wells, R. W., Blennerhassett, M. G. (2004). Persistent and selective effects of inflammation on smooth muscle cell contractility in rat colitis. Pflugers Arch 448, 515-524.
50. Yousif, M. H., Thulesius, O. (1998). Tocolytic effect of the cyclooxygenase-2 inhibitor, meloxicam, studies on uterine contractions in the rat. J. Pharm. Pharmacol. 50, 681-685.
51. Zhang, C., Baumgartner, R. A., Yamada, K. et al. (1997). Beaven MA. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-α and release of arachidonic acid in mast cells, indication of communication between p38 and p42 MAP kinase. J. Biol. Chem. 272, 13397-13402.